)

Arcadia Biosciences (RKDA) investor relations material
Arcadia Biosciences Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Product revenues rose 11% year-over-year for the quarter and 16% for the six months, driven by increased Zola coconut water sales volume following expanded distribution; no price increases were implemented during the period.
The company completed the sale of its GoodWheat brand and RS durum wheat trait in 2024, resulting in discontinued operations and a strategic shift to focus on Zola coconut water.
A $4.5 million credit loss was recognized due to default on a promissory note from Above Food, materially impacting near-term cash resources and financial position.
The company entered into a Securities Exchange Agreement with Roosevelt Resources LP, which, if completed, will result in Roosevelt's limited partners owning 90% of the outstanding shares.
Gross margins exceeded 30% for ten consecutive quarters, with low underlying operating expenses despite $700,000 in transaction fees.
Financial highlights
Net loss from continuing operations was $4.5 million for the quarter, compared to net income of $1.9 million in the prior year; net loss for the six months was $1.9 million versus net income of $0.9 million year-over-year.
Product revenues for the quarter were $1.5 million, up from $1.3 million year-over-year; six-month revenues were $2.7 million, up from $2.3 million.
Operating expenses included a $2.0 million gain from reduction of contingent liabilities and a $750,000 gain from sale of patent portfolios.
Q2 2025 operating expenses were $2.63 million higher than Q2 2024, mainly due to the absence of a $4 million gain from a prior asset sale.
Cash and cash equivalents were $1.4 million as of June 30, 2025, down from $4.2 million at year-end 2024.
Outlook and guidance
Management states that existing cash and cash equivalents are not sufficient to meet anticipated cash requirements for the next 12 months, raising substantial doubt about the ability to continue as a going concern.
Additional funding will be required in the near term; options include debt or equity financings, asset sales, or partner arrangements.
The company is closely monitoring the impact of new U.S. tariffs and may seek to mitigate effects through business partner discussions.
Forward-looking statements highlight risks related to growth, funding, and completion of the Roosevelt Resources transaction.
Next Arcadia Biosciences earnings date

Next Arcadia Biosciences earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage